North America Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity
- 9055A
- Pages: 125
- January 2022
- Total Views:1491
- Region : Global
- Grace Market Data
- Market Research Report
Details
North America autoimmune disease diagnostics market is projected to grow by 7.3% annually in the forecast period and reach USD 4,009.5 million by 2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 28 tables and 67 figures, this 125-page report North America Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Assay Kits & Consumables
Analyzers & Instruments
Based on Test Type, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Autoantibodies and Immunologic Tests
o Antinuclear Antibody Tests
o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests
Inflammatory Marker Tests
o C-Reactive Protein (CRP)
o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests
Routine Laboratory Tests
o Urinalysis
o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests
Other Test Types
Based on Disease Type, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Systemic Autoimmune Disease
o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases
Localized Autoimmune Disease
o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases
Based on Gender, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Female Patients
Male Patients
Based on Age, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
< 44
44 - 64
> 64
Based on End User, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Hospitals
Clinics
Diagnostic Labs
Other End Users
Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table Of Content
Scope
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter's Fiver Forces Analysis 37
3 Segmentation of North America Market by Product 42
3.1 Market Overview by Product 42
3.2 Assay Kits & Consumables 44
3.3 Analyzers & Instruments 45
4 Segmentation of North America Market by Test Type 46
4.1 Market Overview by Test Type 46
4.2 Autoantibodies and Immunologic Tests 48
4.2.1 Antinuclear Antibody Tests 50
4.2.2 Anti-cyclic Citrullinated Peptide 51
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52
4.2.4 Rheumatoid Factor 53
4.2.5 Thyroid Antibody Tests 54
4.2.6 Other Autoantibodies and Immunologic Tests 55
4.3 Inflammatory Marker Tests 56
4.3.1 C-Reactive Protein (CRP) 58
4.3.2 Erythrocyte Sedimentation Rate (ESR) 59
4.3.3 Other Inflammatory Marker Tests 60
4.4 Routine Laboratory Tests 61
4.4.1 Urinalysis 63
4.4.2 Complete Blood Count (CBC) Tests 64
4.4.3 Other Routine Laboratory Tests 65
4.5 Other Test Types 66
5 Segmentation of North America Market by Disease Type 67
5.1 Market Overview by Disease Type 67
5.2 Systemic Autoimmune Disease 69
5.2.1 Rheumatoid Arthritis 71
5.2.2 Systemic Lupus Erythematosus (SLE) 72
5.2.3 Psoriasis/Psoriatic Arthritis 73
5.2.4 Other Systemic Autoimmune Diseases 74
5.3 Localized Autoimmune Disease 75
5.3.1 Thyroiditis 77
5.3.2 Multiple Sclerosis 78
5.3.3 Inflammatory Bowel Disease 79
5.3.4 Type 1 Diabetes 80
5.3.5 Other Localized Autoimmune Diseases 81
6 Segmentation of North America Market by Gender 82
6.1 Market Overview by Gender 82
6.2 Female Patients 84
6.3 Male Patients 85
7 Segmentation of North America Market by Age 86
7.1 Market Overview by Age 86
7.2 < 44 88
7.3 44 - 64 89
7.4 > 64 90
8 Segmentation of North America Market by End User 91
8.1 Market Overview by End User 91
8.2 Hospitals 93
8.3 Clinics 94
8.4 Diagnostic Labs 95
8.5 Other End Users 96
9 North America Market 2021-2031 by Country 97
9.1 Overview of North America Market 97
9.2 U.S. 100
9.3 Canada 103
9.4 Mexico 105
10 Competitive Landscape 107
10.1 Overview of Key Vendors 107
10.2 New Product Launch, Partnership, Investment, and M&A 110
10.3 Company Profiles 111
Abbott Laboratories 111
Beckman Coulter, Inc. 113
Biomerieux SA 114
Bio-rad Laboratories Inc. 115
F. Hoffmann-la Roche Ltd. 116
Hemagen Diagnostics Inc. 117
Myriad Genetics Inc. 118
PerkinElmer Inc. (Euroimmun AG) 119
Quest Diagnostics Inc. 120
Siemens Healthineers Inc. 121
Thermo Fisher Scientific Inc. 122
Trinity Biotech PLC 123
Werfen Company (Inova Diagnostics Inc.) 124
RELATED REPORTS 125
List Of Figure
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Autoimmune Disease Diagnostics Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 9. Primary Restraints and Impact Factors of North America Autoimmune Disease Diagnostics Market 30
Figure 10. Investment Opportunity Analysis 34
Figure 11. Porter's Fiver Forces Analysis of North America Autoimmune Disease Diagnostics Market 37
Figure 12. Breakdown of North America Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 43
Figure 13. North America Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 43
Figure 14. North America Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, USD mn 44
Figure 15. North America Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, USD mn 45
Figure 16. Breakdown of North America Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 47
Figure 17. North America Addressable Market Cap in 2022-2031 by Test Type, Value (USD mn) and Share (%) 47
Figure 18. North America Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, USD mn 48
Figure 19. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, USD mn 50
Figure 20. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, USD mn 51
Figure 21. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, USD mn 52
Figure 22. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, USD mn 53
Figure 23. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, USD mn 54
Figure 24. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, USD mn 55
Figure 25. North America Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, USD mn 56
Figure 26. North America Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, USD mn 58
Figure 27. North America Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, USD mn 59
Figure 28. North America Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, USD mn 60
Figure 29. North America Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, USD mn 61
Figure 30. North America Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, USD mn 63
Figure 31. North America Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, USD mn 64
Figure 32. North America Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, USD mn 65
Figure 33. North America Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, USD mn 66
Figure 34. Breakdown of North America Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 68
Figure 35. North America Addressable Market Cap in 2022-2031 by Disease Type, Value (USD mn) and Share (%) 68
Figure 36. North America Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, USD mn 69
Figure 37. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, USD mn 71
Figure 38. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, USD mn 72
Figure 39. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, USD mn 73
Figure 40. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, USD mn 74
Figure 41. North America Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, USD mn 75
Figure 42. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, USD mn 77
Figure 43. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, USD mn 78
Figure 44. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, USD mn 79
Figure 45. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, USD mn 80
Figure 46. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, USD mn 81
Figure 47. Breakdown of North America Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 83
Figure 48. North America Addressable Market Cap in 2022-2031 by Gender, Value (USD mn) and Share (%) 83
Figure 49. North America Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, USD mn 84
Figure 50. North America Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, USD mn 85
Figure 51. Breakdown of North America Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 87
Figure 52. North America Addressable Market Cap in 2022-2031 by Age, Value (USD mn) and Share (%) 87
Figure 53. North America Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, USD mn 88
Figure 54. North America Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, USD mn 89
Figure 55. North America Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, USD mn 90
Figure 56. Breakdown of North America Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 91
Figure 57. North America Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 92
Figure 58. North America Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, USD mn 93
Figure 59. North America Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, USD mn 94
Figure 60. North America Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, USD mn 95
Figure 61. North America Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 96
Figure 62. Breakdown of North America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 98
Figure 63. Contribution to North America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 99
Figure 64. U.S. Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 101
Figure 65. Canada Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 103
Figure 66. Autoimmune Disease Diagnostics Market in Mexico, 2021-2031, USD mn 105
Figure 67. Growth Stage of North America Autoimmune Disease Diagnostics Industry over the Forecast Period 107
List Of Table
List of Tables:
Table 1. Snapshot of North America Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Health Spending by Region, USD bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Autoimmune Disease Diagnostics Market 33
Table 5. North America Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 42
Table 6. North America Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, USD mn 46
Table 7. North America Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, USD mn 49
Table 8. North America Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, USD mn 57
Table 9. North America Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, USD mn 62
Table 10. North America Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 67
Table 11. North America Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, USD mn 70
Table 12. North America Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, USD mn 76
Table 13. North America Autoimmune Disease Diagnostics Market by Gender, 2021-2031, USD mn 82
Table 14. North America Autoimmune Disease Diagnostics Market by Age, 2021-2031, USD mn 86
Table 15. North America Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 91
Table 16. North America Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 98
Table 17. U.S. Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 102
Table 18. U.S. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 102
Table 19. U.S. Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 102
Table 20. Canada Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 104
Table 21. Canada Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 104
Table 22. Canada Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 104
Table 23. Mexico Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 106
Table 24. Mexico Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 106
Table 25. Mexico Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 106
Table 26. Abbott Laboratories: Company Snapshot 111
Table 27. Abbott Laboratories: Business Segmentation 112
Table 28. Abbott Laboratories: Product Portfolio 112
Licence Rights
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Company Profile
Company Profile Title
North America autoimmune disease diagnostics market is projected to grow by 7.3% annually in the forecast period and reach USD 4,009.5 million by 2031, driven by the growing prevalence of autoimmune diseases, the strong investment in research and development activities, the rise in technological advancements, increasing patient awareness and healthcare expenditure, and favorable government policies.
Highlighted with 28 tables and 67 figures, this 125-page report North America Autoimmune Disease Diagnostics Market 2021-2031 by Product (Assay Kits & Consumables, Analyzers & Instruments), Test Type (Autoantibodies and Immunologic, Inflammatory Marker, Routine Laboratory, Others), Disease Type (Systemic, Localized), Gender (Female, Male), Age (<44, 44-64, >64), End User (Hospitals, Clinics, Diagnostic Labs), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America autoimmune disease diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America autoimmune disease diagnostics market in every aspect of the classification from perspectives of Product, Test Type, Disease Type, Gender, Age, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Assay Kits & Consumables
Analyzers & Instruments
Based on Test Type, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Autoantibodies and Immunologic Tests
o Antinuclear Antibody Tests
o Anti-cyclic Citrullinated Peptide
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Rheumatoid Factor
o Thyroid Antibody Tests
o Other Autoantibodies and Immunologic Tests
Inflammatory Marker Tests
o C-Reactive Protein (CRP)
o Erythrocyte Sedimentation Rate (ESR)
o Other Inflammatory Marker Tests
Routine Laboratory Tests
o Urinalysis
o Complete Blood Count (CBC) Tests
o Other Routine Laboratory Tests
Other Test Types
Based on Disease Type, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Systemic Autoimmune Disease
o Rheumatoid Arthritis
o Systemic Lupus Erythematosus (SLE)
o Psoriasis/Psoriatic Arthritis
o Other Systemic Autoimmune Diseases
Localized Autoimmune Disease
o Thyroiditis
o Multiple Sclerosis
o Inflammatory Bowel Disease
o Type 1 Diabetes
o Other Localized Autoimmune Diseases
Based on Gender, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Female Patients
Male Patients
Based on Age, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
< 44
44 - 64
> 64
Based on End User, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Hospitals
Clinics
Diagnostic Labs
Other End Users
Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Product, Disease Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Scope
1 Introduction 8
1.1 Industry Definition and Research Scope 8
1.1.1 Industry Definition 8
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter's Fiver Forces Analysis 37
3 Segmentation of North America Market by Product 42
3.1 Market Overview by Product 42
3.2 Assay Kits & Consumables 44
3.3 Analyzers & Instruments 45
4 Segmentation of North America Market by Test Type 46
4.1 Market Overview by Test Type 46
4.2 Autoantibodies and Immunologic Tests 48
4.2.1 Antinuclear Antibody Tests 50
4.2.2 Anti-cyclic Citrullinated Peptide 51
4.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) 52
4.2.4 Rheumatoid Factor 53
4.2.5 Thyroid Antibody Tests 54
4.2.6 Other Autoantibodies and Immunologic Tests 55
4.3 Inflammatory Marker Tests 56
4.3.1 C-Reactive Protein (CRP) 58
4.3.2 Erythrocyte Sedimentation Rate (ESR) 59
4.3.3 Other Inflammatory Marker Tests 60
4.4 Routine Laboratory Tests 61
4.4.1 Urinalysis 63
4.4.2 Complete Blood Count (CBC) Tests 64
4.4.3 Other Routine Laboratory Tests 65
4.5 Other Test Types 66
5 Segmentation of North America Market by Disease Type 67
5.1 Market Overview by Disease Type 67
5.2 Systemic Autoimmune Disease 69
5.2.1 Rheumatoid Arthritis 71
5.2.2 Systemic Lupus Erythematosus (SLE) 72
5.2.3 Psoriasis/Psoriatic Arthritis 73
5.2.4 Other Systemic Autoimmune Diseases 74
5.3 Localized Autoimmune Disease 75
5.3.1 Thyroiditis 77
5.3.2 Multiple Sclerosis 78
5.3.3 Inflammatory Bowel Disease 79
5.3.4 Type 1 Diabetes 80
5.3.5 Other Localized Autoimmune Diseases 81
6 Segmentation of North America Market by Gender 82
6.1 Market Overview by Gender 82
6.2 Female Patients 84
6.3 Male Patients 85
7 Segmentation of North America Market by Age 86
7.1 Market Overview by Age 86
7.2 < 44 88
7.3 44 - 64 89
7.4 > 64 90
8 Segmentation of North America Market by End User 91
8.1 Market Overview by End User 91
8.2 Hospitals 93
8.3 Clinics 94
8.4 Diagnostic Labs 95
8.5 Other End Users 96
9 North America Market 2021-2031 by Country 97
9.1 Overview of North America Market 97
9.2 U.S. 100
9.3 Canada 103
9.4 Mexico 105
10 Competitive Landscape 107
10.1 Overview of Key Vendors 107
10.2 New Product Launch, Partnership, Investment, and M&A 110
10.3 Company Profiles 111
Abbott Laboratories 111
Beckman Coulter, Inc. 113
Biomerieux SA 114
Bio-rad Laboratories Inc. 115
F. Hoffmann-la Roche Ltd. 116
Hemagen Diagnostics Inc. 117
Myriad Genetics Inc. 118
PerkinElmer Inc. (Euroimmun AG) 119
Quest Diagnostics Inc. 120
Siemens Healthineers Inc. 121
Thermo Fisher Scientific Inc. 122
Trinity Biotech PLC 123
Werfen Company (Inova Diagnostics Inc.) 124
RELATED REPORTS 125
List Of Figure
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. North America Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of North America Autoimmune Disease Diagnostics Market 25
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 9. Primary Restraints and Impact Factors of North America Autoimmune Disease Diagnostics Market 30
Figure 10. Investment Opportunity Analysis 34
Figure 11. Porter's Fiver Forces Analysis of North America Autoimmune Disease Diagnostics Market 37
Figure 12. Breakdown of North America Autoimmune Disease Diagnostics Market by Product, 2021-2031, % of Revenue 43
Figure 13. North America Addressable Market Cap in 2022-2031 by Product, Value (USD mn) and Share (%) 43
Figure 14. North America Autoimmune Disease Diagnostics Market by Product: Assay Kits & Consumables, 2021-2031, USD mn 44
Figure 15. North America Autoimmune Disease Diagnostics Market by Product: Analyzers & Instruments, 2021-2031, USD mn 45
Figure 16. Breakdown of North America Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, % of Sales Revenue 47
Figure 17. North America Addressable Market Cap in 2022-2031 by Test Type, Value (USD mn) and Share (%) 47
Figure 18. North America Autoimmune Disease Diagnostics Market by Test Type: Autoantibodies and Immunologic Tests, 2021-2031, USD mn 48
Figure 19. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Antinuclear Antibody Tests, 2021-2031, USD mn 50
Figure 20. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Anti-cyclic Citrullinated Peptide, 2021-2031, USD mn 51
Figure 21. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Enzyme-Linked Immunosorbent Assay (ELISA), 2021-2031, USD mn 52
Figure 22. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Rheumatoid Factor, 2021-2031, USD mn 53
Figure 23. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Thyroid Antibody Tests, 2021-2031, USD mn 54
Figure 24. North America Autoimmune Disease Diagnostics Market by Autoantibodies and Immunologic Tests: Other Autoantibodies and Immunologic Tests, 2021-2031, USD mn 55
Figure 25. North America Autoimmune Disease Diagnostics Market by Test Type: Inflammatory Marker Tests, 2021-2031, USD mn 56
Figure 26. North America Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: C-Reactive Protein (CRP), 2021-2031, USD mn 58
Figure 27. North America Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Erythrocyte Sedimentation Rate (ESR), 2021-2031, USD mn 59
Figure 28. North America Autoimmune Disease Diagnostics Market by Inflammatory Marker Tests: Other Inflammatory Marker Tests, 2021-2031, USD mn 60
Figure 29. North America Autoimmune Disease Diagnostics Market by Test Type: Routine Laboratory Tests, 2021-2031, USD mn 61
Figure 30. North America Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Urinalysis, 2021-2031, USD mn 63
Figure 31. North America Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Complete Blood Count (CBC) Tests, 2021-2031, USD mn 64
Figure 32. North America Autoimmune Disease Diagnostics Market by Routine Laboratory Tests: Other Routine Laboratory Tests, 2021-2031, USD mn 65
Figure 33. North America Autoimmune Disease Diagnostics Market by Test Type: Other Test Types, 2021-2031, USD mn 66
Figure 34. Breakdown of North America Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, % of Sales Revenue 68
Figure 35. North America Addressable Market Cap in 2022-2031 by Disease Type, Value (USD mn) and Share (%) 68
Figure 36. North America Autoimmune Disease Diagnostics Market by Disease Type: Systemic Autoimmune Disease, 2021-2031, USD mn 69
Figure 37. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Rheumatoid Arthritis, 2021-2031, USD mn 71
Figure 38. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Systemic Lupus Erythematosus (SLE), 2021-2031, USD mn 72
Figure 39. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Psoriasis/Psoriatic Arthritis, 2021-2031, USD mn 73
Figure 40. North America Autoimmune Disease Diagnostics Market by Systemic Autoimmune Disease: Other Systemic Autoimmune Diseases, 2021-2031, USD mn 74
Figure 41. North America Autoimmune Disease Diagnostics Market by Disease Type: Localized Autoimmune Disease, 2021-2031, USD mn 75
Figure 42. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Thyroiditis, 2021-2031, USD mn 77
Figure 43. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Multiple Sclerosis, 2021-2031, USD mn 78
Figure 44. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Inflammatory Bowel Disease, 2021-2031, USD mn 79
Figure 45. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Type 1 Diabetes, 2021-2031, USD mn 80
Figure 46. North America Autoimmune Disease Diagnostics Market by Localized Autoimmune Disease: Other Localized Autoimmune Diseases, 2021-2031, USD mn 81
Figure 47. Breakdown of North America Autoimmune Disease Diagnostics Market by Gender, 2021-2031, % of Revenue 83
Figure 48. North America Addressable Market Cap in 2022-2031 by Gender, Value (USD mn) and Share (%) 83
Figure 49. North America Autoimmune Disease Diagnostics Market by Gender: Female Patients, 2021-2031, USD mn 84
Figure 50. North America Autoimmune Disease Diagnostics Market by Gender: Male Patients, 2021-2031, USD mn 85
Figure 51. Breakdown of North America Autoimmune Disease Diagnostics Market by Age, 2021-2031, % of Revenue 87
Figure 52. North America Addressable Market Cap in 2022-2031 by Age, Value (USD mn) and Share (%) 87
Figure 53. North America Autoimmune Disease Diagnostics Market by Age: < 44, 2021-2031, USD mn 88
Figure 54. North America Autoimmune Disease Diagnostics Market by Age: 44 - 64, 2021-2031, USD mn 89
Figure 55. North America Autoimmune Disease Diagnostics Market by Age: > 64, 2021-2031, USD mn 90
Figure 56. Breakdown of North America Autoimmune Disease Diagnostics Market by End User, 2021-2031, % of Revenue 91
Figure 57. North America Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 92
Figure 58. North America Autoimmune Disease Diagnostics Market by End User: Hospitals, 2021-2031, USD mn 93
Figure 59. North America Autoimmune Disease Diagnostics Market by End User: Clinics, 2021-2031, USD mn 94
Figure 60. North America Autoimmune Disease Diagnostics Market by End User: Diagnostic Labs, 2021-2031, USD mn 95
Figure 61. North America Autoimmune Disease Diagnostics Market by End User: Other End Users, 2021-2031, USD mn 96
Figure 62. Breakdown of North America Autoimmune Disease Diagnostics Market by Country, 2021 and 2031, % of Revenue 98
Figure 63. Contribution to North America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 99
Figure 64. U.S. Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 101
Figure 65. Canada Autoimmune Disease Diagnostics Market, 2021-2031, USD mn 103
Figure 66. Autoimmune Disease Diagnostics Market in Mexico, 2021-2031, USD mn 105
Figure 67. Growth Stage of North America Autoimmune Disease Diagnostics Industry over the Forecast Period 107
List Of Table
List of Tables:
Table 1. Snapshot of North America Autoimmune Disease Diagnostics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Health Spending by Region, USD bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Autoimmune Disease Diagnostics Market 33
Table 5. North America Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 42
Table 6. North America Autoimmune Disease Diagnostics Market by Test Type, 2021-2031, USD mn 46
Table 7. North America Autoimmune Disease Diagnostics Market: Autoantibodies and Immunologic Tests by Type, 2021-2031, USD mn 49
Table 8. North America Autoimmune Disease Diagnostics Market: Inflammatory Marker Tests by Type, 2021-2031, USD mn 57
Table 9. North America Autoimmune Disease Diagnostics Market: Routine Laboratory Tests by Type, 2021-2031, USD mn 62
Table 10. North America Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 67
Table 11. North America Autoimmune Disease Diagnostics Market: Systemic Autoimmune Disease by Type, 2021-2031, USD mn 70
Table 12. North America Autoimmune Disease Diagnostics Market: Localized Autoimmune Disease by Type, 2021-2031, USD mn 76
Table 13. North America Autoimmune Disease Diagnostics Market by Gender, 2021-2031, USD mn 82
Table 14. North America Autoimmune Disease Diagnostics Market by Age, 2021-2031, USD mn 86
Table 15. North America Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 91
Table 16. North America Autoimmune Disease Diagnostics Market by Country, 2021-2031, USD mn 98
Table 17. U.S. Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 102
Table 18. U.S. Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 102
Table 19. U.S. Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 102
Table 20. Canada Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 104
Table 21. Canada Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 104
Table 22. Canada Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 104
Table 23. Mexico Autoimmune Disease Diagnostics Market by Product, 2021-2031, USD mn 106
Table 24. Mexico Autoimmune Disease Diagnostics Market by Disease Type, 2021-2031, USD mn 106
Table 25. Mexico Autoimmune Disease Diagnostics Market by End User, 2021-2031, USD mn 106
Table 26. Abbott Laboratories: Company Snapshot 111
Table 27. Abbott Laboratories: Business Segmentation 112
Table 28. Abbott Laboratories: Product Portfolio 112
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Selected Key Players:
Abbott Laboratories
Beckman Coulter, Inc.
Biomerieux SA
Bio-rad Laboratories Inc.
F. Hoffmann-la Roche Ltd.
Hemagen Diagnostics Inc.
Myriad Genetics Inc.
PerkinElmer Inc. (Euroimmun AG)
Quest Diagnostics Inc.
Siemens Healthineers Inc.
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Company (Inova Diagnostics Inc.)
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
: +91 9015378249
Related Reports
Page 157 | 
June 2021
Page 130 | December 2020
Page 130 | December 2020
Page 131 | November 2020
Page 95 | November 2020